Coclaurine N-methyltransferase from Coptis japonica catalyzes the N-methylation of coclaurine as well as simple tetrahydroisoquinoline. We examined the possibility of converting 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline into its N-methylated product using transgenic Escherichia coli, which expressed recombinant coclaurine N-methyltransferase, without the addition of a methyl-group donor. Transgenic E. coli successfully N-methylated the substrate added to the medium and excreted the product. Limitation of bioconversion by the supply of methyl-group donor is discussed.
The cells of higher plants produce a wide variety of secondary metabolites, including more than 25,000 terpenoids, about 8,000 phenolic compounds, and about 12,000 alkaloids. These chemicals are used as dyes, fragrances, flavoring agents, and in important pharmaceuticals. 1) Recently, several researchers have investigated biosynthetic activities in secondary metabolism for the bioconversion of chemicals, since secondary metabolic enzymes often show highly regio-and stereospecific reaction activity. Whereas the easiest application of secondary metabolism in plant cells is the bioconversion of chemicals with intact cells, this is often inadequate because of the relatively low activity in intact/cultured plant cells and the low recovery of metabolites due to complicated compartmentation in plant cells as well as uncontrolled catabolic reactions. 2, 3) To overcome the problems encountered in using intact plant cells, purified biosynthetic enzymes have been used. For example, Amann and Zenk reported that immobilized (S)-tetrahydroprotoberberine oxidase was useful for the stereospecific oxidation of (S)-norreticuline. 4) Furthermore, recent progresses in the isolation of biosynthetic enzyme genes and their expression in heterologous hosts have provided abundant catalysts for enzymological bioconversion. However, enzymatic bioconversion often requires an expensive co-factor(s), which limits its practical application.
Transgenic microbial cells that express recombinant biosynthetic enzymes may overcome the problems in the production of secondary metabolites.
5) The heterologous expression of a recombinant enzyme can provide large amounts of biocatalysts within a short period on a small scale, and recombinant cells themselves can supply the co-factors for bioconversion. Furthermore, the metabolites are expected to be excreted. The usefulness of transgenic microbial cells has been previously demonstrated in transgenic E. coli cells, which converted hyoscyamine into scopolamine without the addition of 2-oxoglutarate. 6) But, the application of transgenic microbial cells is still limited.
To evaluate the usefulness of transgenic microbial cells that express a recombinant secondary metabolic enzyme, we examined the N-methylation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (DMTHIQ) by transgenic E. coli expressing coclaurine N-methyltransferase (CNMT) from Coptis japonica (Fig. 1) . Since this y To whom correspondence should be addressed. Tel: +81-75-753-6381; Fax: +81-75-753-6398; E-mail: fumihiko@kais.kyoto-u.ac.jp Abbreviations: DMTHIQ, 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline; CNMT, coclaurine N-methyltransferase; AdoMet, S-adenosyl-L-methionine; AdoHcy, S-adenosyl-L-homocysteine; LC/MS, liquid chromatography-mass spectrometry enzymatic conversion requires stoichiometric amounts of expensive S-adenosyl-L-methionine (AdoMet) as a methyl group donor, 7) the regeneration system of AdoMet in E. coli cells should be useful for maintaining in vivo methylation activity during bioconversion.
In a previous paper, we found that recombinant Coptis CNMT has quite broad substrate specificity, i.e., relatively high N-methylation activity even for simple isoquinolines. 7) This broad substrate specificity prompted us to test the in vivo bioconversion of DMTHIQ, as a model substrate, using transgenic E. coli that expressed Coptis CNMT.
E. coli vector for expressing Coptis CNMT was constructed, and heterologous expression of CNMT was induced as described previously 7) with some modification. After 1 mM isopropylthiogalactoside was added to induce the production of recombinant CNMT, E. coli cells were incubated at 25 C. After 4 hours' induction, in vitro activity was measured using the crude cell lysate as described previously.
7) Thirty ml of cultured cells (OD 600 ¼ 1:6) produced about 1.6 nkat in vitro activity of CNMT. This activity was calculated to be sufficient to convert about 2 mM DMTHIQ added to 30 ml of culture medium. After the induction of recombinant CNMT production, 0.5 mM DMTHIQ was added to the culture medium, then the E. coli cells were further incubated at 25 C for 4 hours. The culture medium was analyzed by liquid chromatography-mass spectrometry (LC/MS). The culture medium was centrifuged and the supernatant was extracted by a Sep-Pak C18 cartridge (Waters). The extract was analyzed by LC/MS with an LCMS-2010 system (Shimadzu; column, TSKgel ODS-80Tm, 250 mm length Â 4 mm i.d.; TOSOH; mobile phase, 32% acetonitrile/H 2 O containing 1% acetic acid; flow rate, 0.3 ml/min).
LC/MS analysis showed that the reaction product with a 14-m=z greater mass was detected in the culture medium of transgenic E. coli cells (Fig. 2) and identical to N-methylated DMTHIQ prepared by the in vitro CNMT reaction. This reaction product was not detected in the culture medium of control E. coli cells that had been transformed with the control vector (data not shown). This result suggested that transgenic E. coli provided methyl-group donor, AdoMet, and recombinant CNMT converted the substrate in vivo. Our result also suggest that bioconverted product was excreted into the medium and can be easily recovered without cell extraction. When transgenic E. coli cells were harvested and extracted by methanol, LC/MS analysis showed that almost all of product was secreted into the medium (data not shown).
Next we examined the longevity of the bioconversion activity and regeneration activity for methyl-group donor. Transgenic E. coli culture without enrichment showed linear bioconversion activity up to 14 h (Fig. 3A) . After 14 h, the conversion ratio reached almost 30% of the substrate. The measurement of in vitro CNMT activity also showed that total activity per flask for DMTHIQ was almost constant throughout the culture period. These results showed that E. coli cells maintained a high activity of CNMT and a steady regeneration activity for methyl-group donor.
Since transgenic E. coli showed high bioconversion activity, we examined the effect of E. coli density on the bioconversion activity. We concentrated transgenic E. coli four-fold by centrifugation and incubated them with the substrate. As shown in Fig. 3A , concentrated E. coli also showed linear bioconversion activity. They converted 30% of the substrate within 2 h and about 80% after 14 h. Overall, the results suggest that bioconversion activity was maintained in transgenic E. coli within this duration of incubation.
To investigate the effect of the substrate concentration, we measured the bioconversion activity within a relatively short period (20 min). Within this time period, the N-methylation reaction was saturated at a relatively low concentration of DMTHIQ, e.g., lower than 0.1 mM (Fig. 3B) . However, transgenic E. coli cells converted only ca. 20% of 2 mM substrate during incubation overnight (14 h). An excess amount of substrate (5, 8 or 10 mM) did not increase the product and did not affect E. coli growth. Since the in vitro activity of CNMT in E. coli culture, ca. 1.6 nkat/30 ml culture (OD 600 ¼ 1:6), was calculated to convert 2 mM substrate in 30 ml of reaction mixture for 11 h under optimum conditions, this conversion rate seemed rather low. Since CNMT activity in E. coli after 14 h of incubation was as high as at the beginning of the reaction, low methyl-group donor regeneration may limit the efficiency of bioconversion. Improving co-factor regeneration is crucial for efficient bioconversion in transgenic cells. Alternatively, substrate transport/export also may limit the bioconversion efficiency.
When the bioconversion activity of cultured C. japonica cells was compared with that of transgenic E. coli, cultured C. japonica cells showed an activity of 4.8 pkat on the basis of 1 g fresh weight, and this activity corresponded to 90 l culture (OD 600 ¼ 1:6) of transgenic E. coli after induction with isopropylthiogalactoside. When seven-day-old cultured cells (6 g fresh weight) were incubated in 100 ml culture medium with 0.5 mM DMTHIQ for 2 or 5 days, only a small amount of N-methylated product was detected in the culture medium by LS/MS analysis (data not shown). These results again suggest the benefits of transgenic E. coli compared to plant cells, which have complex compartmentation and low activity.
Our results also suggest that the functional expression of N-methyltransferase and its screening with whole transgenic cells may be useful for the functional screening of N-methyltransferase(s) as well as other methyltransferase(s). Furthermore, the in vivo bioconversion activity of transgenic microorganisms and their ability to excrete the product are important components in reconstructing an entire biosynthetic pathway using a series of transgenic microorganisms.
